Erlotinib-associated interstitial pneumonitis with successful readministration
Article in Journal of Oncology Pharmacy Practice (July 2023)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
At the crossroads of inflammation and fibrosis: epiregulin
Article in Annals of the Rheumatic Diseases (February 2023)
Immune-related adverse events of cancer immunotherapies targeting kinases
Article in Pharmacology & Therapeutics (July 2022)